12 citations
,
April 1995 in “Journal of Medicinal Chemistry”
The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.
2 citations
,
December 2021 in “International Journal of Andrology”
Most legal cases about 5α-reductaseinhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.
The post is a humorous take on the author's experience with hair loss and using finasteride for six months. The conversation includes discussions about hair loss, treatments like finasteride, and personal experiences with baldness.
GHK-Cu is a potent inhibitor of the type 1 5-alphareductase enzyme in hair follicles, which may reduce hair loss without the side effects associated with type 2 5-alphareductaseinhibitors. The user previously experienced side effects with 5-alphareductaseinhibitors and is considering GHK-Cu as an alternative.
The conversation discusses the need for a localized 5-alphareductaseinhibitor that only affects the scalp without systemic side effects, similar to pyrilutamide's approach. Current treatments like topical liposomal finasteride and dutasteride are mentioned, but concerns about their systemic effects and lack of research are highlighted.
Pumpkin Seed Oil and Perilla Oil (with alpha-lipoic acid, linoleic acid, and oleic acid) are discussed as potential 5alpha-reductaseinhibitors. The conversation focuses on their effectiveness for hair loss treatment.
The conversation discusses the mechanism of action of alfatradiol (17 alpha estradiol) in treating hair loss. It explores theories that it either inhibits 5 alphareductase to prevent T->DHT conversion or aromatizes scalp T into 17-alpha-estradiol to save hair.